Your browser doesn't support javascript.
loading
Do schizotypal or borderline personality disorders predict onset of psychotic disorder or persistent attenuated psychotic symptoms in patients at high clinical risk?
Hadar, H; Zhang, H; Phillips, L J; Amminger, G P; Berger, G E; Chen, E Y H; de Haan, L; Hartmann, J A; Hickie, I B; Lavoie, S; Markulev, C; McGorry, P D; Mossaheb, N; Nieman, D H; Nordentoft, M; Riecher-Rössler, A; Schäfer, M R; Schlögelhofer, M; Smesny, S; Thompson, A; Verma, S; Yuen, H P; Yung, A R; Nelson, B.
Afiliación
  • Hadar H; Psychology Department, University of Otago, Dunedin, New Zealand.
  • Zhang H; Melbourne School of Psychological Sciences, The University of Melbourne, Melbourne, VIC, Australia.
  • Phillips LJ; Melbourne School of Psychological Sciences, The University of Melbourne, Melbourne, VIC, Australia.
  • Amminger GP; Centre for Youth Mental Health, The University of Melbourne, VIC, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia.
  • Berger GE; Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, University of Zurich, Zurich, Switzerland.
  • Chen EYH; Department of Psychiatry, University of Hong Kong, Hong Kong, Hong Kong.
  • de Haan L; Department of Psychiatry, Amsterdam UMC, Academic Medical Center, Amsterdam, Netherlands.
  • Hartmann JA; Centre for Youth Mental Health, The University of Melbourne, VIC, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia.
  • Hickie IB; Brain and Mind Research Institute, University of Sydney, Sydney, NSW, Australia.
  • Lavoie S; Centre for Youth Mental Health, The University of Melbourne, VIC, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia.
  • Markulev C; Centre for Youth Mental Health, The University of Melbourne, VIC, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia.
  • McGorry PD; Centre for Youth Mental Health, The University of Melbourne, VIC, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia.
  • Mossaheb N; Department of Psychiatry and Psychotherapy, Clinical Division of Social Psychiatry, Medical University Vienna, Vienna, Austria; Department of Child and Adolescent Psychiatry, Medical University Vienna, Vienna, Austria.
  • Nieman DH; Department of Psychiatry, Amsterdam UMC, Academic Medical Center, Amsterdam, Netherlands.
  • Nordentoft M; Psychiatric Centre Bispebjerg, Copenhagen, Denmark.
  • Riecher-Rössler A; Psychiatric University Clinics Basel, Basel, Switzerland.
  • Schäfer MR; Centre for Youth Mental Health, The University of Melbourne, VIC, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia.
  • Schlögelhofer M; Department of Psychiatry and Psychotherapy, Clinical Division of Social Psychiatry, Medical University Vienna, Vienna, Austria.
  • Smesny S; Department of Psychiatry, University Hospital Jena, Jena, Germany.
  • Thompson A; Centre for Youth Mental Health, The University of Melbourne, VIC, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia.
  • Verma S; Institute of Mental Health, Singapore, Singapore.
  • Yuen HP; Centre for Youth Mental Health, The University of Melbourne, VIC, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia.
  • Yung AR; Centre for Youth Mental Health, The University of Melbourne, VIC, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia; Institute of Brain, Behaviour, and Mental Health, University of Manchester, Manchester, United Kingdom.
  • Nelson B; Centre for Youth Mental Health, The University of Melbourne, VIC, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, VIC, Australia. Electronic address: barnaby.nelson@orygen.org.au.
Schizophr Res ; 220: 275-277, 2020 06.
Article en En | MEDLINE | ID: mdl-32305167
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Trastorno de la Personalidad Esquizotípica / Trastorno de Personalidad Limítrofe Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Schizophr Res Asunto de la revista: PSIQUIATRIA Año: 2020 Tipo del documento: Article País de afiliación: Nueva Zelanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Trastorno de la Personalidad Esquizotípica / Trastorno de Personalidad Limítrofe Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Schizophr Res Asunto de la revista: PSIQUIATRIA Año: 2020 Tipo del documento: Article País de afiliación: Nueva Zelanda